A carregar...
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib
BACKGROUND: Objective response of advanced adrenocortical carcinoma (ACC) to mitotane and cytotoxic chemotherapy regimen is only ~20% and early tumor progression is frequent. Previous clinical trials with oral multikinase inhibitors were negative, which has been attributed in part to inadvertent dru...
Na minha lista:
| Publicado no: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204945/ https://ncbi.nlm.nih.gov/pubmed/31900481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgz318 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|